Plan for a healthy pregnancy and learn how your genes could affect your future family
LEARN MORECondition guides and resources to support you through the genetic testing process
Learn moreInvitae's genetic counselors are available by phone to answer questions
Learn moreAnswers to common questions about genetic testing with Invitae
Visit help centerDisorder | Gene |
---|---|
11-beta-hydroxylase-deficient congenital adrenal hyperplasia |
CYP11B1 |
17-alpha-hydroxylase-deficient congenital adrenal hyperplasia |
CYP17A1 |
3-beta-hydroxysteroid dehydrogenase type II deficiency (Congenital adrenal hyperplasia) |
HSD3B2 |
3-hydroxy-3-methylglutarayl-CoA (HMG-CoA) lyase deficiency |
HMGCL |
3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency (MCC1-related) |
MCCC1 |
3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency (MCC2-related) |
MCCC2 |
3-methylglutaconic aciduria type III (Costeff optic atrophy) |
OPA3 |
ACAD9 deficiency |
ACAD9 |
Abetalipoproteinemia |
MTTP |
Achromatopsia (CNGB3-related) |
CNGB3 |
Acrodermatitis enteropathica |
SLC39A4 |
Adenosine deaminase deficiency |
ADA |
Aicardi-Goutieres syndrome (SAMHD1-related) |
SAMHD1 |
Aldosterone synthase deficiency |
CYP11B2 |
Alkaptonuria |
HGD |
Alpha-1 antitrypsin deficiency |
SERPINA1 |
Alpha-mannosidosis |
MAN2B1 |
Alpha-thalassemia |
HBA1, HBA2 |
Alpha-thalassemia X-linked intellectual disability syndrome |
ATRX |
Alport Syndrome (COL4A3-related) |
COL4A3 |
Alport Syndrome (COL4A4-related) |
COL4A4 |
Alport Syndrome, X-linked (COL4A5-related) |
COL4A5 |
Alström syndrome |
ALMS1 |
Andermann syndrome |
SLC12A6 |
Arginase deficiency |
ARG1 |
Argininosuccinic aciduria |
ASL |
Aromatase deficiency |
CYP19A1 |
Asparagine synthetase deficiency |
ASNS |
Aspartylglucosaminuria |
AGA |
Ataxia with vitamin E deficiency |
TTPA |
Ataxia-telangiectasia |
ATM |
Autoimmune polyendocrinopathy with candidiasis and ectodermal dysplasia |
AIRE |
Autosomal recessive deafness 77 (DFNB77) |
LOXHD1 |
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) |
SACS |
Bardet-Biedl syndrome (BBS1-related) |
BBS1 |
Bardet-Biedl syndrome (BBS10-related) |
BBS10 |
Bardet-Biedl syndrome (BBS12-related) |
BBS12 |
Bardet-Biedl syndrome (BBS2-related) |
BBS2 |
Bartter syndrome type IV |
BSND |
Bernard-Soulier syndrome (GP1BA-related) |
GP1BA |
Bernard-Soulier syndrome (GP9-related) |
GP9 |
Beta-ketothiolase deficiency |
ACAT1 |
Biotinidase deficiency |
BTD |
Bloom syndrome |
BLM |
Canavan disease |
ASPA |
Carbamoylphosphate synthetase I deficiency |
CPS1 |
Carnitine palmitoyltransferase I deficiency |
CPT1A |
Carnitine palmitoyltransferase II deficiency |
CPT2 |
Carpenter Syndrome |
RAB23 |
Cartilage-hair hypoplasia-anauxetic dysplasia spectrum disorders |
RMRP |
Cerebrotendinous xanthomatosis |
CYP27A1 |
Charcot-Marie-Tooth disease (NDRG1-related) |
NDRG1 |
Charcot-Marie-Tooth disease, X-linked (GJB1-related) |
GJB1 |
Chorea-acanthocytosis |
VPS13A |
Choroideremia |
CHM |
Chronic granulomatous disease (CYBA-related) |
CYBA |
Chronic granulomatous disease (CYBB-related) |
CYBB |
Citrin deficiency |
SLC25A13 |
Citrullinemia type 1 |
ASS1 |
Cockayne syndrome type A |
ERCC8 |
Cockayne syndrome type B |
ERCC6 |
Cohen syndrome |
VPS13B |
Combined SAP Deficiency |
PSAP |
Combined malonic and methylmalonic aciduria (ACSF3-related) |
ACSF3 |
Combined oxidative phosphorylation deficiency (GFM1-related) |
GFM1 |
Combined oxidative phosphorylation deficiency (TSFM-related) |
TSFM |
Combined pituitary hormone deficiency (LHX3-related) |
LHX3 |
Combined pituitary hormone deficiency (PROP1-related) |
PROP1 |
Congenital amegakaryocytic thrombocytopenia |
MPL |
Congenital disorder of glycosylation (ALG6-related) |
ALG6 |
Congenital disorder of glycosylation (MPI-related) |
MPI |
Congenital disorders of glycosylation (PMM2-related) |
PMM2 |
Congenital ichthyosis (TGM1-related) |
TGM1 |
Congenital insensitivity to pain with anhidrosis |
NTRK1 |
Congenital myasthenic syndrome (CHRNE-related) |
CHRNE |
Congenital myasthenic syndrome (RAPSN-related) |
RAPSN |
Congenital neutropenia (HAX1-related) |
HAX1 |
Corneal dystrophy and perceptive deafness |
SLC4A11 |
Cystic fibrosis/ CFTR-related disorders |
CFTR |
Cystinosis |
CTNS |
D-bifunctional protein deficiency |
HSD17B4 |
DHDDS-related disorders (including Congenital disorder of glycoslylation/ Retinitis pigmentosa 59) |
DHDDS |
DMD-related dystrophinopathy (Including Duchenne/Becker muscular dystrophy and Dilated cardiomyopathy) |
DMD |
Dihydrolipoamide dehydrogenase deficiency (DLD) |
DLD |
Dysferlinopathy (including Limb-girdle muscular dystrophy type 2B) |
DYSF |
Dystrophic epidermolysis bullosa (COL7A1-related) |
COL7A1 |
Ehlers-Danlos syndrome type VIIC |
ADAMTS2 |
Ellis-van Creveld syndrome (EVC-related) |
EVC |
Ellis-van Creveld syndrome (EVC2-related) |
EVC2 |
Emery-Dreifuss muscular dystrophy (EMD-related) |
EMD |
Enhanced S-cone syndrome/ Retinitis pigmentosa 37 |
NR2E3 |
Ethylmalonic encephalopathy |
ETHE1 |
Fabry disease |
GLA |
Factor IX deficiency (Hemophilia B) |
F9 |
Factor V Leiden thrombophilia |
F5 |
Factor XI deficiency (Hemophilia C) |
F11 |
Familial dysautonomia |
ELP1 |
Familial hypercholesterolemia (LDLR-related) |
LDLR |
Familial hypercholesterolemia (LDLRAP1-related) |
LDLRAP1 |
Familial hyperinsulinism (ABCC8-related) |
ABCC8 |
Familial hyperinsulinism (KCNJ11-related) |
KCNJ11 |
Familial mediterranean fever |
MEFV |
Fanconi anemia type A |
FANCA |
Fanconi anemia type C |
FANCC |
Fanconi anemia type G |
FANCG |
Fragile X syndrome |
FMR1 |
Fumarate hydratase deficiency |
FH |
GJB2-related DFNB1 nonsyndromic hearing loss and deafness |
GJB2 |
GRACILE syndrome/ BCS1L-related disorders (including Mitochondrial complex III deficiency, Bjornstad syndrome, Leigh syndrome) |
BCS1L |
Galactokinase deficiency galactosemia |
GALK1 |
Galactosemia |
GALT |
Gaucher disease |
GBA |
Gitelman syndrome |
SLC12A3 |
Glucose-6-phosphate dehydrogenase (G6PD) deficiency |
G6PD |
Glutaric acidemia type I |
GCDH |
Glutaric acidemia type II (ETFA-related) |
ETFA |
Glutaric acidemia type II (ETFDH-related) |
ETFDH |
Glycine encephalopathy (AMT-related) |
AMT |
Glycine encephalopathy (GLDC-related) |
GLDC |
Glycogen storage disease type II (Pompe disease) |
GAA |
Glycogen storage disease type III |
AGL |
Glycogen storage disease type IV/ Adult polyglucosan body disease |
GBE1 |
Glycogen storage disease type Ia |
G6PC |
Glycogen storage disease type Ib |
SLC37A4 |
Glycogen storage disease type V |
PYGM |
Glycogen storage disease type VII |
PFKM |
Guanidinoacetate methyltransferase deficiency |
GAMT |
HBB-related hemoglobinopathies (including Beta-thalassemia and Sickle cell disease) |
HBB |
Hereditary fructose intolerance |
ALDOB |
Hereditary hemochromatosis (HFE-related) |
HFE |
Hereditary hemochromatosis (HJV-related) |
HJV |
Hereditary hemochromatosis (TFR2-related) |
TFR2 |
Hermansky-Pudlak syndrome (HPS1-related) |
HPS1 |
Hermansky-Pudlak syndrome (HPS3-related) |
HPS3 |
Holocarboxylase synthetase deficiency |
HLCS |
Homocystinuria (CBS-related) |
CBS |
Homocystinuria due to MTHFR deficiency |
MTHFR |
Homocystinuria, cobalamin E type |
MTRR |
Hydrolethalus syndrome type 1 |
HYLS1 |
Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome |
SLC25A15 |
Hypohidrotic ectodermal dysplasia (EDA-related) |
EDA |
Hypophosphatasia |
ALPL |
Inclusion body myopathy 2 |
GNE |
Isovaleric acidemia |
IVD |
Joubert syndrome 2/ TMEM216-related disorders |
TMEM216 |
Junctional epidermolysis bullosa (LAMA3-related) |
LAMA3 |
Junctional epidermolysis bullosa (LAMB3-related) |
LAMB3 |
Junctional epidermolysis bullosa (LAMC2-related) |
LAMC2 |
Krabbe disease |
GALC |
LAMA2-related muscular dystrophy |
LAMA2 |
Disorder | Gene |
---|---|
Leber congenital amaurosis 10/ CEP290-related disorders |
CEP290 |
Leber congenital amaurosis 13 |
RDH12 |
Leber congenital amaurosis 2 |
RPE65 |
Leber congenital amaurosis 5 |
LCA5 |
Leber congenital amaurosis 8/ CRB1-related disorders |
CRB1 |
Leigh syndrome, French Canadian type |
LRPPRC |
Lethal congenital contracture syndrome 1 / Lethal arthrogryposis with anterior horn cell disease |
GLE1 |
Leukoencephalopathy with vanishing white matter (EIF2B5-related) |
EIF2B5 |
Limb-girdle muscular dystrophy type 2A/Calpainopathy |
CAPN3 |
Limb-girdle muscular dystrophy type 2C |
SGCG |
Limb-girdle muscular dystrophy type 2D |
SGCA |
Limb-girdle muscular dystrophy type 2E |
SGCB |
Lipoid congenital adrenal hyperplasia |
STAR |
Lipoprotein lipase deficiency |
LPL |
Long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency |
HADHA |
Lysinuric protein intolerance |
SLC7A7 |
Lysosomal acid lipase deficiency (includes Wolman disease and Cholesterol ester storage disease) |
LIPA |
MKS1-related disorders |
MKS1 |
Major histocompatibility complex class II deficiency |
CIITA |
Maple syrup urine disease (MSUD) type 1A |
BCKDHA |
Maple syrup urine disease (MSUD) type 1B |
BCKDHB |
Maple syrup urine disease (MSUD) type 2 |
DBT |
Medium chain acyl-CoA dehydrogenase (MCAD) deficiency |
ACADM |
Megalencephalic leukoencephalopathy with subcortical cysts type 1 |
MLC1 |
Menkes disease/ ATP7A-related disorders (including Occipital horn syndrome and Distal hereditary motor neuropathy) |
ATP7A |
Metachromatic leukodystrophy |
ARSA |
Methylmalonic acidemia (MMAA-related) |
MMAA |
Methylmalonic acidemia (MMAB-related) |
MMAB |
Methylmalonic acidemia (MUT-related) |
MUT |
Methylmalonic acidemia with homocystinuria, cobalamin C type |
MMACHC |
Methylmalonic acidemia with homocystinuria, cobalamin D type |
MMADHC |
Microphthalmia / clinical anophthalmia |
VSX2 |
Mitochondrial DNA depletion syndrome |
MPV17 |
Mitochondrial complex I deficiency/ Leigh syndrome (NDUFAF5-related) |
NDUFAF5 |
Mitochondrial complex I deficiency/ Leigh syndrome (NDUFS6- related) |
NDUFS6 |
Mitochondrial myopathy and sideroblastic anemia 1 |
PUS1 |
Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease |
TYMP |
Mucolipidosis type II/III (GNPTAB-related) |
GNPTAB |
Mucolipidosis type III (GNPTG-related) |
GNPTG |
Mucolipidosis type IV |
MCOLN1 |
Mucopolysaccharidosis type I (includes Hurler, Hurler-Scheie, and Scheie syndromes) |
IDUA |
Mucopolysaccharidosis type II (Hunter syndrome) |
IDS |
Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome) |
SGSH |
Mucopolysaccharidosis type IIIB |
NAGLU |
Mucopolysaccharidosis type IIIC (Sanfilippo syndrome)/ Retinitis pigmentosa 73 |
HGSNAT |
Mucopolysaccharidosis type IIID (Sanfilippo syndrome) |
GNS |
Mucopolysaccharidosis type IVB (Morquio B syndrome)/ GM1 gangliosidosis |
GLB1 |
Mucopolysaccharidosis type IX |
HYAL1 |
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) |
ARSB |
Multiple sulfatase deficiency |
SUMF1 |
N-Acetylglutamate synthase deficiency |
NAGS |
Nemaline myopathy 2 |
NEB |
Nephrogenic diabetes insipidus (AQP2-related) |
AQP2 |
Nephrotic syndrome/ Congenital Finnish nephrosis (NPHS1-related) |
NPHS1 |
Nephrotic syndrome/Steroid-resistant nephrotic syndrome (NPHS2-related) |
NPHS2 |
Neuronal ceroid lipofuscinosis (TPP1-related) |
TPP1 |
Neuronal ceroid-lipofuscinosis (CLN3-related) |
CLN3 |
Neuronal ceroid-lipofuscinosis (CLN5-related) |
CLN5 |
Neuronal ceroid-lipofuscinosis (CLN6-related) |
CLN6 |
Neuronal ceroid-lipofuscinosis (MFSD8-related) |
MFSD8 |
Neuronal ceroid-lipofuscinosis (PPT1-related) |
PPT1 |
Neuronal ceroid-lipofuscinosis/ Northern epilepsy (CLN8-related) |
CLN8 |
Niemann-Pick disease type A/B |
SMPD1 |
Niemann-Pick disease type C (NPC1-related) |
NPC1 |
Niemann-Pick disease type C (NPC2-related) |
NPC2 |
Nijmegen breakage syndrome |
NBN |
Ornithine aminotransferase deficiency |
OAT |
Ornithine transcarbamylase (OTC) deficiency |
OTC |
Osteopetrosis (TCIRG1-related) |
TCIRG1 |
POMGNT1-related disorders (including Muscle eye brain disease) |
POMGNT1 |
PRPS1-related disorders (including Charcot-Marie-Tooth disease type 5 and Arts syndrome) |
PRPS1 |
Pendred syndrome |
SLC26A4 |
Peroxisomal acyl-CoA oxidase deficiency |
ACOX1 |
Phenylalanine hydroxylase deficiency (including Phenylketonuria (PKU)) |
PAH |
Phosphoglycerate dehydrogenase deficiency/ Neu-Laxova syndrome |
PHGDH |
Polycystic kidney disease (PKHD1-related) |
PKHD1 |
Polymicrogyria (ADGRG1-related) |
ADGRG1 |
Pontocerebellar hypoplasia (RARS2-related) |
RARS2 |
Pontocerebellar hypoplasia (SEPSECS-related) |
SEPSECS |
Pontocerebellar hypoplasia (VRK1-related) |
VRK1 |
Postnatal progressive microcephaly with seizures and brain atrophy/ Infantile cerebral and cerebellar atrophy (MED17-related) |
MED17 |
Primary Ciliary Dyskinesia (DNAH5-related) |
DNAH5 |
Primary Ciliary Dyskinesia (DNAI1-related) |
DNAI1 |
Primary Ciliary Dyskinesia (DNAI2-related) |
DNAI2 |
Primary carnitine deficiency |
SLC22A5 |
Primary hyperoxaluria type 1 |
AGXT |
Primary hyperoxaluria type 2 |
GRHPR |
Primary hyperoxaluria type 3 |
HOGA1 |
Progressive familial intrahepatic cholestasis type 2 |
ABCB11 |
Propionic acidemia (PCCA-related) |
PCCA |
Propionic acidemia (PCCB-related) |
PCCB |
Prothrombin-related thrombophilia |
F2 |
Pycnodysostosis |
CTSK |
Pyruvate carboxylase deficiency |
PC |
Pyruvate dehydrogenase deficiency (PDHA1-related) |
PDHA1 |
Pyruvate dehydrogenase deficiency (PDHB-related) |
PDHB |
RPGRIP1L-related disorders (including Joubert syndrome 7, COACH syndrome and Meckel syndrome 5) |
RPGRIP1L |
RTEL-1-related disorders (including Dyskeratosis congenita) |
RTEL1 |
Renal tubular acidosis with deafness (ATP6V1B1-related) |
ATP6V1B1 |
Retinitis Pigmentosa 28 |
FAM161A |
Retinitis pigmentosa 25 |
EYS |
Retinitis pigmentosa 26 |
CERKL |
Rhizomelic chondrodysplasia punctata type 1/ Refsum disease (PEX7-related) |
PEX7 |
Rhizomelic chondrodysplasia punctata type 3 |
AGPS |
Roberts syndrome |
ESCO2 |
SLC26A2-related disorders (including Diatrophic dysplasia, Atelosteogenesis type 2, Achondrogenesis type 1B/ Multiple metaphyseal dysplasia) |
SLC26A2 |
SLC35A3-related disorder |
SLC35A3 |
Sandhoff disease |
HEXB |
Schimke immuno-osseous dysplasia |
SMARCAL1 |
Severe combined immune deficiency (DCLRE1C-related) |
DCLRE1C |
Severe combined immunodeficiency/ Omenn syndrome (RAG2-related) |
RAG2 |
Severe congenital neutropenia (VPS45-related) |
VPS45 |
Sialic acid storage disorders |
SLC17A5 |
Sjögren-Larsson syndrome |
ALDH3A2 |
Smith-Lemli-Opitz syndrome |
DHCR7 |
Spastic paraplegia type 15 |
ZFYVE26 |
Spastic paraplegia type 49 |
TECPR2 |
Spinal muscular atrophy |
SMN1 |
Spondylothoracic dysostosis |
MESP2 |
Steel Syndrome |
COL27A1 |
Stüve-Wiedemann syndrome |
LIFR |
Tay-Sachs disease/ Hexosaminidase A deficiency |
HEXA |
Tetrahydrobiopterin deficiency (PTS-related) |
PTS |
Transient infantile liver failure (TRMU-related) |
TRMU |
Tyrosine hydroxylase deficiency |
TH |
Tyrosinemia type I |
FAH |
Tyrosinemia type II |
TAT |
Usher syndrome type IB/ MYO7A-related disorders |
MYO7A |
Usher syndrome type IC/ USH1C-related disorders |
USH1C |
Usher syndrome type ID |
CDH23 |
Usher syndrome type IF/ PCDH15-related disorders |
PCDH15 |
Usher syndrome type IIA/ USH2A-related disorders |
USH2A |
Usher syndrome type IIIA |
CLRN1 |
Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency |
ACADVL |
WNT10A-related disorders (including Odonto-onycho-dermal dysplasia and Schopf-Schulz-Passarge syndrome) |
WNT10A |
Walker-Warburg syndrome/ FKRP-related disorders |
FKRP |
Walker-Warburg syndrome/ FKTN-related disorders |
FKTN |
Wilson disease |
ATP7B |
X-linked adrenoleukodystrophy |
ABCD1 |
X-linked creatine transporter deficiency |
SLC6A8 |
X-linked juvenile retinoschisis |
RS1 |
X-linked myotubular myopathy |
MTM1 |
X-linked severe combined immunodeficiency (X-SCID) |
IL2RG |
Xeroderma pigmentosum complemetation group A |
XPA |
Xeroderma pigmentosum complemetation group C |
XPC |
Zellweger spectrum disorder (PEX1-related) |
PEX1 |
Zellweger spectrum disorder (PEX10-related) |
PEX10 |
Zellweger spectrum disorder (PEX12-related) |
PEX12 |
Zellweger spectrum disorder (PEX2-related) |
PEX2 |
Zellweger spectrum disorder (PEX6-related) |
PEX6 |